Last synced on 25 January 2026 at 3:41 am

Immunoassay, Pregnanediol Glucuronide, Over The Counter

Page Type
Product Code
Definition
Over-the-counter detection of pregnanediol glucuronide for the confirmation of ovulation
Physical State
Immunoassay.
Technical Method
Immunoassay.
Target Area
In vitro diagnostic device.
Regulation Medical Specialty
Chemistry
Review Panel
Toxicology
Submission Type
510(K) Exempt
Device Classification
Class 1
Regulation Number
862.1620
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

CFR § 862.1620 Progesterone test system

§ 862.1620 Progesterone test system.

(a) Identification. A progesterone test system is a device intended to measure progesterone (a female hormone) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of disorders of the ovaries or placenta.

(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.

[52 FR 16122, May 1, 1987, as amended at 65 FR 2308, Jan. 14, 2000]

Immunoassay, Pregnanediol Glucuronide, Over The Counter

Page Type
Product Code
Definition
Over-the-counter detection of pregnanediol glucuronide for the confirmation of ovulation
Physical State
Immunoassay.
Technical Method
Immunoassay.
Target Area
In vitro diagnostic device.
Regulation Medical Specialty
Chemistry
Review Panel
Toxicology
Submission Type
510(K) Exempt
Device Classification
Class 1
Regulation Number
862.1620
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

CFR § 862.1620 Progesterone test system

§ 862.1620 Progesterone test system.

(a) Identification. A progesterone test system is a device intended to measure progesterone (a female hormone) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of disorders of the ovaries or placenta.

(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.

[52 FR 16122, May 1, 1987, as amended at 65 FR 2308, Jan. 14, 2000]